SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Curtis Frazier who wrote (20037)3/24/1999 10:11:00 AM
From: Mkilloran  Read Replies (1) of 23519
 
Curtis...Yes Alibra will be Vivus's second ED product
It's in Phase III FDA testing now . Expected to be completed and submitted for final FDA approval by 3rd qtr 99. Should be on the market selling early in yr 2000.

It is much less expensive to produce (more profit potential for Vivus), it is more effective than MUSE, it is a smaller pellet thus the new patent to redesign the applicator, (Vivus employees have nick named Alibra "The Little GUY"). Alibra does not need to be kept in the fridge it can be stored at room temp.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News